Related Experiment Video

Updated: Apr 23, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.3K

Acute regulation of PDK1 by a complex interplay of molecular switches

Veronique Calleja, Michel Laguerre1, Gloria de Las Heras-Martinez2

  • 1‡Institut Européen de Chimie et Biologie, Université de Bordeaux, UMR 5248, 2 rue Robert Escarpit, F-33607 Pessac, France.

Biochemical Society Transactions
|September 19, 2014
PubMed

Insights

Phosphoinositide-dependent kinase 1 (PDK1) controls many kinases involved in cancer. This review details how molecular mechanisms regulate PDK1 conformation and activation, offering therapeutic insights.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Phosphoinositide-dependent kinase 1 (PDK1) is a crucial regulator of the AGC kinase family.
  • Dysregulation of PDK1 signaling is implicated in various diseases, notably cancer.
  • Understanding PDK1 regulation is vital for developing targeted therapies.

Purpose of the Study:

  • To review the molecular mechanisms governing PDK1 regulation.
  • To elucidate how these mechanisms control PDK1's spatial and temporal activity.
  • To highlight the role of conformational regulation in PDK1 activation.

Main Methods:

  • Review of existing literature on PDK1 regulation.
  • Analysis of studies investigating phosphorylation (serine/threonine and tyrosine).
  • Examination of research on subcellular localization, regulator binding, and conformational changes.

Main Results:

  • PDK1 activation is a complex process involving multiple regulatory layers.
  • Serine/threonine and tyrosine phosphorylation significantly impact PDK1 activity.
  • Subcellular localization and binding partners are critical for PDK1 function.

Conclusions:

  • PDK1 conformation is tightly regulated by a combination of molecular events.
  • These regulatory mechanisms collectively control PDK1 activation in cellular contexts.
  • Further understanding of PDK1 regulation may unlock new therapeutic strategies for cancer.

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.0K
Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

6.1K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
100.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K